Literature DB >> 15308381

The metabolic syndrome.

Alan J Garber1.   

Abstract

This article provides an overview of the metabolic syndrome, a collection of cardiovascular risk factors that denote a high-risk, multifactorial,adverse cardiovascular state, which is largely the result of obesity and resulting insulin resistance. Treatment for the metabolic syndrome should be focused primarily on modifying lifestyle,with reduction of the underlying obesity and insulin resistance. A combination of chemoprevention and lifestyle modification may prevent many if not most cases of diabetes if treatment is instituted early.

Entities:  

Mesh:

Year:  2004        PMID: 15308381     DOI: 10.1016/j.mcna.2004.04.001

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  11 in total

1.  Changes in anthropometric measurements, body composition, blood pressure, lipid profile, and testosterone in patients participating in a low-energy dietary intervention.

Authors:  Mary Balliett; Jeanmarie R Burke
Journal:  J Chiropr Med       Date:  2013-03

2.  Unraveling the links between diabetes, obesity, and cardiovascular disease.

Authors:  Paul L Huang
Journal:  Circ Res       Date:  2005-06-10       Impact factor: 17.367

3.  Anandamide-derived prostamide F2α negatively regulates adipogenesis.

Authors:  Cristoforo Silvestri; Andrea Martella; Neil J Poloso; Fabiana Piscitelli; Raffaele Capasso; Angelo Izzo; David F Woodward; Vincenzo Di Marzo
Journal:  J Biol Chem       Date:  2013-06-25       Impact factor: 5.157

4.  CD36 protein influences myocardial Ca2+ homeostasis and phospholipid metabolism: conduction anomalies in CD36-deficient mice during fasting.

Authors:  Terri A Pietka; Matthew S Sulkin; Ondrej Kuda; Wei Wang; Dequan Zhou; Kathryn A Yamada; Kui Yang; Xiong Su; Richard W Gross; Jeanne M Nerbonne; Igor R Efimov; Nada A Abumrad
Journal:  J Biol Chem       Date:  2012-09-27       Impact factor: 5.157

5.  Understanding the causal factors of obesity using the International Classification of Functioning, Disability and Health.

Authors:  Keisha Tyler Robinson; James Butler
Journal:  Disabil Rehabil       Date:  2010-08-09       Impact factor: 3.033

6.  Metabolic syndrome: prevalence among American Indian and Alaska native people living in the southwestern United States and in Alaska.

Authors:  Catherine Schumacher; Elizabeth D Ferucci; Anne P Lanier; Martha L Slattery; Cynthia D Schraer; Terry W Raymer; Denise Dillard; Maureen A Murtaugh; Lillian Tom-Orme
Journal:  Metab Syndr Relat Disord       Date:  2008-12       Impact factor: 1.894

7.  The framingham risk score, diet, and inflammatory markers in Korean men with metabolic syndrome.

Authors:  Cheongmin Sohn; Juyong Kim; Wookyung Bae
Journal:  Nutr Res Pract       Date:  2012-06-30       Impact factor: 1.926

Review 8.  Lipids: A Suitable Therapeutic Target in Diabetic Neuropathy?

Authors:  M C Perez-Matos; M C Morales-Alvarez; C O Mendivil
Journal:  J Diabetes Res       Date:  2017-01-16       Impact factor: 4.011

9.  High-glucose 3D INS-1 cell model combined with a microfluidic circular concentration gradient generator for high throughput screening of drugs against type 2 diabetes.

Authors:  Yong Luo; Xiuli Zhang; Yujiao Li; Jiu Deng; Xiaorui Li; Yueyang Qu; Yao Lu; Tingjiao Liu; Zhigang Gao; Bingcheng Lin
Journal:  RSC Adv       Date:  2018-07-16       Impact factor: 4.036

10.  Prevalence of Metabolic Syndrome in Middle School Children and Evaluation of Components of Metabolic Syndrome.

Authors:  Gizem Kara Elitok; Nilgün Selçuk Duru; Murat Elevli; Zuhal Aydan Sağlam; Kubilay Karşıdağ
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2019-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.